Get started
Author

Guilherme Andriatte

Observed names: G.M. Andriatte, Guilherme Malandrini Andriatte
OpenAlex ID: A5019869560
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development
2022 · Douglas Dias e Silva, Guilherme Malandrini Andriatte, et al. · The Cancer Journal · 2
Disparities in Non-Small Cell Lung Cancer: Epidemiology and Molecular Testing in Brazil's Public and Private Healthcare Systems
2026 · Yuri Greb Vazquez, Douglas Dias, et al. · Brazilian Journal of Oncology
EP.17.30 Rising Incidence of Early Onset Thoracic Malignant Tumors: Real-World Data From Two Hospitals in Brazil
2025 · B.V. Miyamura, D.V. Markus, et al. · Journal of Thoracic Oncology
Access Barriers to Pembrolizumab in Brazil
2025 · Pedro Luiz Serrano Uson Junior, Uelson Donizeti Rocioli, et al. · JAMA Network Open
PDF
EP.11A.20 Incidence and Outcomes of Adrenal Oligoprogression in Metastatic Lung Cancer During Immunotherapy
2024 · B.V. Miyamura, F.C. Maluf, et al. · Journal of Thoracic Oncology
PDF
Proper management of patients using doxorubicin: Request for a transthoracic echocardiogram prior to initiating therapy.
2023 · Guilherme Andriatte, Larissa Zuppardi Lacerda Sabino, et al. · JCO Oncology Practice
Works count: 6
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type